Speculative, but we need more pharma companies to make immunotherapy drugs.
Stock price when the opinion was issued
As of Sep 02, 2026. Market Open.
He likes their model, and there is no demand for their products.
Build your watch list
Sign in to track investmentsyou care about
CNBC
iA Global Asset Management
Stone Castle Investment Management Inc.
Stockchase Premium
Stockchase
Speculative, but we need more pharma companies to make immunotherapy drugs.